We are live on ! Find out more
ACUR

Acura Pharmaceuticals
ACUR

Delisted

ACUR was delisted on the 22nd of February, 2017.

Back to rankings

43 hedge funds and large institutions have $23.1M invested in Acura Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 43 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

73% less call options, than puts

Call options by funds: $37K | Put options by funds: $138K

Holders
43
Holders Change
+43
Holders Change %
–
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
43
Increased
–
Reduced
–
Closed
–
Calls
$37K
Puts
$138K
Net Calls
-$101K
Net Calls Change
-$101K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Nomura Holdings
26
Nomura Holdings
Japan
$32K +$38.4K +3,396 New
KCG
27
Knight Capital Group
$31K +$37.9K +3,356 New
BIT
28
BlackRock Institutional Trust
California
$25K +$29.9K +2,650 New
PPA
29
Parametric Portfolio Associates
Washington
$24K +$29.3K +2,590 New
Jane Street
30
Jane Street
New York
$23K +$27.1K +2,400 New
State Street
31
State Street
Massachusetts
$23K +$27.2K +2,406 New
OC
32
Oppenheimer & Co
New York
$19K +$22.6K +2,000 New
AIG
33
American International Group
New York
$15.7K +$18.8K +1,668 New
TRCT
34
Tower Research Capital (TRC)
New York
$12K +$14.7K +1,302 New
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$11K +$14.1K +1,251 New
U
36
UBS
Switzerland
$10K +$11.8K +1,040 New
NFA
37
Nationwide Fund Advisors
Ohio
$10K +$11.9K +1,056 New
Group One Trading
38
Group One Trading
Illinois
$9K +$10.6K +934 New
BA
39
BlackRock Advisors
Delaware
$6K +$6.92K +613 New
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K +$4.41K +390 New
Ameriprise
41
Ameriprise
Minnesota
$2K +$2.19K +194 New
Citigroup
42
Citigroup
New York
– +$68 +6 New
RFC
43
Russell Frank Company
Washington
– +$169 +15 New
1
2

ACUR Hedge Fund Activity: Q2 2013 in Review

43 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q2 2013, worth a combined $23.1M.

Buyers outnumbered sellers: 43 funds opened new ACUR positions and 0 closed out — a net gain of 43 holders — while 0 added to existing stakes and 0 trimmed.

  • 43 institutional investors held Acura Pharmaceuticals (ACUR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $23.1M of Acura Pharmaceuticals stock for Q2 2013.
  • 43 funds opened new Acura Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +43 holders.

Based on aggregated 13F filings for Q2 2013.